Cost Effectiveness of Ambulatory Management for Veterans With Sleep Apnea
VSATT
Cost Effective Strategy to Evaluate Veterans With Sleep Apnea
1 other identifier
interventional
296
1 country
2
Brief Summary
This research study is comparing home and in-laboratory testing of veterans with suspected obstructive sleep apnea, a common breathing disorder during sleep. It is hoped that home testing will be equally effective in improving quality of life but have lower cost than in-lab testing. These findings will allow veterans to have greater access to diagnosis and treatment of their sleep apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2006
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
April 10, 2009
CompletedFirst Posted
Study publicly available on registry
April 13, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedResults Posted
Study results publicly available
April 21, 2014
CompletedApril 21, 2014
March 1, 2014
2.7 years
April 10, 2009
January 8, 2014
March 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cost
VA sleep-study and treatment medical service use will be derived from the case report form; and costed out using VA acquisition costs. Other medical service use will be derived from VA administrative records. Non-VA medical service use will be derived from patient interview and will be costed out using federal reimbursement schedules. Costs will be stratified by whether or not they are related to the diagnosis and treatment of OSA.Cost and preferences are assessed for each entire arm.
Medical service use and cost will be collected every 3 months for the entire observation period. Thus the shortest duration of follow-up in the study is anticipated to be 3 months, while the longest will be 2.25 years.
Secondary Outcomes (2)
Functional Outcome of Sleep Questionnaire
3 months
Continuous Positive Airway Pressure Adherence
3 months
Study Arms (2)
Arm 1
ACTIVE COMPARATORIn-laboratory testing followed by continuous positive airway pressure treatment
Arm 2
ACTIVE COMPARATORHome unattended testing followed by continuous positive airway pressure treatment
Interventions
Veterans randomized to both arms who are diagnosed with obstructive sleep apnea will be started on treatment with continuous positive airway pressure.
Eligibility Criteria
You may qualify if:
- Individuals willing to participate must meet the following eligibility criteria prior to enrollment:
- Patients referred for a sleep evaluation for suspected sleep apnea.
- Age 18 years or older
- Living within 90 miles of the Sleep Center.
You may not qualify if:
- Individuals will be excluded from the study for the following reasons:
- Unable or unwilling to provide informed written consent.
- Lack of telephone access or inability to return for follow-up testing.
- A history of prior sleep evaluations, OSA treatment, or sleep disorder in addition to OSA.
- A clinically unstable chronic medical condition as defined by a new diagnosis or change in medical management in the previous 3 months of cardiac disease, thyroid disease, diabetes, depression or psychosis, cirrhosis, or recently diagnosed cancer.
- Individuals already on long term oxygen therapy or requiring bilevel positive airway pressure.
- Individuals with rotating shift work or irregular work schedules over the last 6 months.
- Suspected or confirmed to be pregnant. A pregnancy test will be performed using the urine sample obtained at the initial visit.
- Inability to complete the Assessment Battery - e.g. less than a 5th grade reading level
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- US Department of Veterans Affairslead
- University of Pennsylvaniacollaborator
Study Sites (2)
Leonard Davis Institute of Health Economics
Philadelphia, Pennsylvania, 19104-6128, United States
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, 15240, United States
Related Publications (2)
Sunwoo B, Kuna ST. Ambulatory management of patients with sleep apnea: is there a place for portable monitor testing? Clin Chest Med. 2010 Jun;31(2):299-308. doi: 10.1016/j.ccm.2010.02.003.
PMID: 20488288RESULTKuna ST, Gurubhagavatula I, Maislin G, Hin S, Hartwig KC, McCloskey S, Hachadoorian R, Hurley S, Gupta R, Staley B, Atwood CW. Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea. Am J Respir Crit Care Med. 2011 May 1;183(9):1238-44. doi: 10.1164/rccm.201011-1770OC. Epub 2011 Jan 21.
PMID: 21471093RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Samuel T. Kuna, MD
- Organization
- Philadelphia VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel T. Kuna, MD
VA Medical Center, Philadelphia
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2009
First Posted
April 13, 2009
Study Start
November 1, 2006
Primary Completion
July 1, 2009
Study Completion
January 1, 2010
Last Updated
April 21, 2014
Results First Posted
April 21, 2014
Record last verified: 2014-03